OR WAIT null SECS
Illustrates that majority of pharma sales were made through organization’s traditional distributor network
Data published yesterday by the Healthcare Distribution Alliance (HDA) Research Foundation revealed that in 2019, approximately 93% of all US pharma sales were completed through HDA-member traditional pharmaceutical distributors. As reported in the 91st Edition HDA Factbook, total distributor sales were $519 billion.
The Factbook is based on surveys collected at the corporate level of HDA traditional distributor member companies with yearly sales greater than $1 billion, along with secondary data included from healthcare and governmental organizations. The data reflect distribution industry performance metrics and overall supply chain management trends for the 2019 operating year; it should be noted that this edition does not reflect the effects of Covid-19 on supply chain operations.
Prescription drugs accounted for about $420 billion of distributors’ overall pharmaceutical sales, representing a nearly 6% growth over 2018—distributors worked with more than 1,400 manufacturer suppliers.
Among the other findings: